This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Discovery Labs Announces Recent AFECTAIR® Publications

WARRINGTON, Pa., May 1, 2013 /PRNewswire/ -- Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, today announced the release of two peer-reviewed publications related to AFECTAIR ®, the Company's proprietary aerosol-conducting airway connector designed with the goal of simplifying and improving aerosolized medication delivery to infants requiring mechanical ventilation in the neonatal and pediatric intensive care units.  

"Discovery Labs has had a long-standing commitment to presenting our scientific findings through the peer review process, thereby providing the scientific rigor and transparency expected by healthcare professionals today," said Dr. Russell G. Clayton, Senior Vice President, Research & Development, of Discovery Labs.  "Our goal is to better inform healthcare professionals about our products and the patients who might benefit from our novel technologies."

The two publications are as follows:

Aerosolized albuterol sulfate delivery under neonatal ventilatory conditions – in vitro evaluation of a novel ventilator circuit patient interface connector - Journal of Aerosol Medicine and Pulmonary Delivery. March 2013, Volume 26, Number 0, 2013, Pages 1-8

The goal of this in vitro study, previously presented at the 2012 Hot Topics in Neonatology Annual Meeting, was to characterize the delivery of aerosolized albuterol sulfate, a medication commonly delivered in aerosolized form, under simulated neonatal ventilatory conditions using AFECTAIR.  Authors of the study found that use of AFECTAIR resulted in an increased delivery of albuterol sulfate at the patient interface compared with the method currently used to introduce aerosolized medication into the ventilator circuit.  In addition, the aerosol characteristics at the patient interface were more consistent with the aerosol characteristics produced by the nebulizer when the aerosolized medication was delivered through AFECTAIR compared with the currently used method.   Authors concluded that AFECTAIR may be a useful, new approach for the delivery of aerosolized medications to neonates requiring positive pressure ventilatory support.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.66 -0.09%
FB $118.58 0.85%
GOOG $698.30 0.76%
TSLA $241.82 0.44%
YHOO $36.53 -0.19%


Chart of I:DJI
DOW 17,891.16 +117.52 0.66%
S&P 500 2,081.43 +16.13 0.78%
NASDAQ 4,817.5940 +42.2360 0.88%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs